聚焦欧洲疾控中心-2026年脑膜炎奈瑟菌鉴定、抗菌药物敏感性试验和分子分型的外部质量评估(英)-2026。Figure 2. Performance on meningococcal non-culture samples: serogroup reporting for NC1 and NC4 (expected:;Figure 3. Culture-based serogroup performance for meningococcal isolates N1 and N2 (expected: serogroup W for。
聚焦欧洲疾控中心-2026年脑膜炎奈瑟菌鉴定、抗菌药物敏感性试验和分子分型的外部质量评估(英)-2026。Figure 2. Performance on meningococcal non-culture samples: serogroup reporting for NC1 and NC4 (expected:;Figure 3. Culture-based serogroup performance for meningococcal isolates N1 and N2 (expected: serogroup W for。
聚焦欧洲疾控中心-2026年脑膜炎奈瑟菌鉴定、抗菌药物敏感性试验和分子分型的外部质量评估(英)-2026。Figure 2. Performance on meningococcal non-culture samples: serogroup reporting for NC1 and NC4 (expected:;Figure 3. Culture-based serogroup performance for meningococcal isolates N1 and N2 (expected: serogroup W for。
覆盖 2026 年,全文共 26 页。
本报告为付费报告,可在资料宝站内下单后获取完整内容。
重点分析了药物、欧洲疾控中心、2026年脑膜炎奈瑟菌鉴定等议题。